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Acute viral encephalitis caused by neurotrophic viruses, such 
as mosquito-borne flaviviruses, is an emerging and re-emerg-
ing disease that represents an immense global health 
problem. Considerable progression has been made in under-
standing the pathogenesis of acute viral encephalitis, but the 
immune-pathological processes occurring during the pro-
gression of encephalitis and the roles played by various mol-
ecules and cellular components of the innate and adaptive 
systems still remain undefined. Recent findings reveal the 
significant contribution of Toll-like receptors (TLRs) and reg-
ulatory CD4
＋ T cells in the outcomes of infectious diseases 
caused by neurotrophic viruses. In this review, we discuss the 
ample evidence focused on the roles of TLRs and CD4
＋ 
helper T cell subsets on the progression of acute viral 
encephalitis. Finally, we draw attention to the importance of 
these molecules and cellular components in defining the 
pathogenesis of acute viral encephalitis, thereby providing 
new therapeutic avenues for this disease.
[Immune Network 2012;12(2):48-57]
INTRODUCTION
Encephalitis is ٘the presence of an inflammatory process of 
the  brain  associated  with  clinical  evidence  of  neurological 
dysfunction,ٙ as defined by the Infectious Diseases Society of 
America  (1).  Though  more  than  one  hundred  different  in-
fectious agents that cause acute encephalitis have been identi-
fied, viral infections are responsible for the majority of cases 
of infectious encephalitis. Viral infections in the central nerv-
ous system (CNS) can alter homeostasis, induce neurological 
dysfunction, and result in serious, potentially life-threatening 
inflammatory diseases. Viruses that can cause acute encepha-
litis include rabies virus, herpes simplex virus (HSV), flavivi-
ruses such as the West Nile virus (WNV) and Japanese ence-
phalitis  virus  (JEV),  and  enterovirus  including  polioviruses, 
coxackie  viruses,  and  echoviruses.
    In healthy individuals, the number of lymphocytes that traf-
fic into the CNS is very low and tightly controlled by the high-
l y  s p e c i a l i z e d  b l o o d - b r a i n  b a r r i e r  ( B B B ) .  H o w e v e r ,  n e u r o -
trophic viruses can strategically cross the barrier systems of 
the CNS. The restricted expression of MHC antigens and the 
nonrenewable nature of the neuron cells offer additional chal-
lenges for the  immune system to detect  and to respond to 
viral infections of the CNS. The actual mechanism by which 
the virus reaches the CNS is not entirely defined. It may be 
possible that Langerhan cells or macrophages, as primary tar-
get cells, may be infected with viruses and then pass into the 
lymph node closest to the site of infection (2). These infected 
innate cells can then subsequently enter into the circulation 
following a brief replication in the lymph node via the effer-
ent  lymphatic  system  and  the  thoracic  duct.  This  results  in 
viremia, as the viruses ultimately reach the CNS (3). Recently, 
it has been reported that signaling through Toll-like receptors 
plays a key role in crossing the BBB by the encephalitis-caus-
ing viruses and influence the development ofneurological dis-
orders (4). Although encephalitis caused by neurotrophic vi-TLRs and CD4
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ruses is well-characterized in the evidence of immune system 
recognition  and  the  presence  of  inflammatory  components 
during  the  neuropathological  changes  (5),  there  are  only  a 
few studies describing the role of CD4
＋ helper T cell (Th) 
subsets,  in  particular  the  CD4
＋CD25
＋Foxp3
＋ T r e g ,  d u r i n g  
the  progression  of  an  infection  caused  by  neurotrophic  vi-
ruses (6). The purpose of this review is to provide the outline 
of accumulated evidences focused on their role in encephali-
tis  caused  by  neurotrophic  viruses.
ACUTE VIRAL ENCEPHALITIS WITH SPECIAL 
EMPHASIS ON JAPANESE ENCEPHALITIS
Emerging  diseases  are  defined  as  diseases  that  have  newly 
appeared  as  a  threat  to  public  health  or  have  existed  pre-
viously  but  are  rapidly  increasing  in  incidence  or  in  geo-
graphical range (7). The mosquito-borne flavivirus, rising in 
incidence by global warming and modern transportation, is 
one of the most important examples of emerging and resurg-
ing diseases of global significance (8). Mosquito-borne flavivi-
ruses with rapidly expanding ranges includes WNV, JEV, as 
well as the dengue virus. Notably, the introduction of WNV 
into  North  America  from  the  Middle  East  (9-11)  and  the 
spread  of  JEV  into  India,  Nepal,  and  northern  Australia 
(12-15) are typical examples of these mechanisms. The ma-
jority of flaviviruses are zoonoses that depend on animal spe-
cies other than human for their maintenance in nature, with 
the notable exception of the dengue virus. Humans are usu-
ally incidental and dead-end hosts that do not contribute to 
the  natural  transmission  cycle.  When  introduced  in  New 
York,  probably  through  air  transport,  WNV  infected  many 
susceptible mosquitoes and bird species to establish an en-
demic  cycle  and  spread  rapidly  across  America  (9-11). 
Similarly,  JEV is now  rapidly  expanded  into  previously  un-
affected regions, such as Indonesia, Pakistan, and the north-
ern Australia (12-15). Furthermore, southern California of the 
United States is at particular risk for the introduction of JEV, 
due to its large size and function as a hub for international 
travel and commerce with Asia, which is a potential risk with 
high introduction frequency of mosquitoes infected with JEV. 
Similarly to WNV, if JEV is introduced into the U.S., the virus 
might get established rapidly, due to the large number of sus-
ceptible  mosquito  vectors  and  vertebrate  hosts.
    Nowadays,  it  is  estimated  that  30,000  to  50,000  cases  of 
JE  occur  each  year,  resulting  in  10,000  to  15,000  deaths. 
However, the actual number of cases may be underestimated 
due to social and political problems (16,17). Transmission oc-
curs primarily via Culex tritaeniorrhyncus and Culex vishnui 
mosquitoes, which also transmit WNV. Water birds, including 
herons and egrets, serve as natural reservoirs and domestic 
pigs as an important amplifying host (17-21). JEV targets the 
CNS,  clinically  manifesting  with  fever,  headache,  vomiting, 
signs of meningeal irritation, and altered consciousness lead-
ing to high mortality and persistent neurological sequel in the 
s u r v i v o r s  ( 2 2 ) .  I n  m a n y  c a s e s ,  J E V  i s  p r o b a b l y  n o t  d i r e c t l y 
involved  in  the  destruction  of  brain  tissue  but  may  cause 
damage indirectly by abnormal activation of cell-mediated im-
mune  responses  as  well  as  activation  of  microglia  and  as-
trocytes (23). Indeed, it has been reported that various pro-in-
flammatory  mediators  like  IFN-α,  TNF-α,  M I F ,  I L - 8 ,  I L - 6 ,  
RANTES, COX-2, IL-1β, MCP-1 are elevated during a JEV in-
fection  (23,24).  Moreover,  high  mortality  rates  were  asso-
ciated with increased concentrations of cytokines in sera and 
CSF of the victims (25). Also, the protective role of other im-
portant  anti-inflammatory  mediators,  i.e.  IL-4,  IL-10,  and 
iNOS,  was  demonstrated  (26).
INVOLVEMENT OF TLRs IN THE PROGRESSION OF 
ACUTE VIRAL ENCEPHALITIS
Overview of TLR family
TLRs were first described in Drosophila on the basis of their 
homology to the protein Toll. A search for homologous pro-
teins in mammals revealed the TLRs. TLRs are Type-I trans-
membrane pattern recognition proteins with a variable num-
ber of N-terminal leucine rich repeats (LRRs) followed by a 
cysteine-rich domain, a transmembrane (TM) domain, and an 
intracellular Toll/IL-1 receptor (TIR) domain. TLRs are crucial 
in the innate immune response to microbial pathogens, where 
they recognize and respond to pathogen-associated molecular 
patterns (PAMPs), which lead to the activation of intracellular 
signaling pathways and altered gene expression. In mammals, 
TLRs  function  as  intermediates  by  interacting  with  products 
of infectious agents and then transmitting the signals to a cas-
cade of adapters and kinases that ultimately lead transcription 
of pro-inflammatory cytokines (27). These cytokines activate 
innate  immune  cells  (eg.  macrophages,  dendritic  cells,  NK 
cells, and neutrophils), which in turn leads to the activation 
of the adaptive immune system. Intracellular and extracellular 
TLRs  can recognize a wide range of  viruses  leading to the 
production  of  various  cytokines.  Of  these,  the  most  critical 
in the host defense mechanism against viruses includes the TLRs and CD4
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type-I  interferons  (IFN),  IFN-α and  IFN-β (28).
  M o s t  m a m m a l i a n  s p e c i e s  h a v e  b e e n  r e p o r t e d  t o  e x p r e s s  
between  ten  and  fifteen  type  of  TLRs.  The  TLR  family  can 
be divided into five subfamilies: TLR2, TLR3, TLR4, TLR5, and 
TLR9. TLR2 subfamily is composed of TLR1, TLR2, TLR6, and 
TLR10. TLR2 forms heterodimers with TLR1, TLR6 (29-34) and 
probably  TLR10  (30),  and  each  TLR2-complex  heterodimer 
has a distinct ligand specificity. TLR2 recognizes a wide range 
of  PAMPs  such  as  lipoproteins,  lipoteichoic  acid  (from 
Gram-negative bacteria), lipoarabinomannan (from mycobac-
teria),  glycosylphophatidylinositol  anchor  (from  T.  cruzi), 
phenol-soluble modulin (from S. epidermis), zymosan (from 
fungi),  and  glycolipids  (from  Treponema  maltophilum) 
(29-33). TLR2 can also recognize viruses, including the mea-
sles virus (MV), human cytomegalovirus (HCMV), and hep-
atitis C virus (HCV) (35,36). TLR3 forms a homodimer and 
recognizes the viral double stranded RNA (dsRNA), which is 
generated during the viral replication, and induces IFN-α/β 
synthesis leading to various anti-viral effects and immune re-
sponses by the host (30-33). TLR4 forms a homodimer and 
recognizes  lipopolysaccharide  (LPS)  from  Gram-negative 
bacteria. This recognition process is enhanced by LPS-binding 
p r o t e i n  ( L B P ) ,  w h i c h  c a r r i e s  L P S  t o  t h e  C D 1 4  m o l e c u l e ,  
where  it  is  then  presented  to  the  MD-2-TLR4  complex 
(29-33). The TLR4 complex also recognizes a few other bacte-
rial PAMPs including LTA. Moreover, the TLR4 complex rec-
ognizes viruses such as the respiratory syncytial virus (RSV), 
hepatitis  C  virus  (HCV),  and  mouse  mammary  tumor  virus 
(MMTV) (29-33,36,37). TLR5 can form a homodimer as well 
as a hetrodimer with TLR4. TLR5 recognizes bacterial flagellin 
of both Gram-positive and Gram-negative bacteria (38). TLR5 
is expressed on the epithelial cells of the airways, intestine, 
and urogenitial tract. Interestingly, expression of TLR5 on the 
intestinal epithelium is polarized such that TLR5 is expressed 
only on the basolateral side of the cell (39). TLR7 recognizes 
SYNTHETIC  immunomodulators  such  as  imidazoquinolone 
compounds,  which  can  be  used  against  human  papil-
lomavirus (HPV) infections (32,33). TLR9 recognizes synthetic 
CpG  oligonucleotides  and  the  unmethylated  CpG  motifs  in 
bacterial and viral DNA, initiating a signaling cascade leading 
to  the  production  of  proinflammatory  cytokines  (29-33,40).
Recognition of encephalitis-causing viruses by TLRs
Only limited information exists on the role of TLRs and their 
signaling in neurological diseases caused by viral infections. 
The majority of known studies involve encephalitis caused by 
the flavivirus infection such as WNV and JEV. A protective 
role  for  TLR7  and  MyD88  in  WNV  infection  has  been  re-
ported, as mice deficient in these molecules were more vul-
nerable to WNV-induced encephalitis (41,42). Both TLR7- and 
MyD88-deficient mice showed a defect in leukocyte migration 
to the WNV-infected tissues, which correlated with decreased 
levels of IL-23. Paradoxically, systemic levels of pro-inflam-
matory  cytokines  and  type-I  IFN  were  higher  in  TLR7-defi-
cient mice than wild-type mice (41), indicating that the abro-
gation  of  the  TLR7  pathway  had  little  systemic  impact  on 
type-I IFN production after WNV infection. In contrast, little 
effect on the systemic type-I IFN responses was observed in 
MyD88-deficient mice (41). The varying roles of TLR3 mole-
cule  in  WNV-induced  encephalitis  have  also  been  demon-
strated. TLR3-deficient mice exhibited improved survival rates 
after WNV infection, likely due to decreased inflammatory cy-
tokine  responses  that  may  induce  decreased  BBB  perme-
a b i l i t y  a n d  e a r l y  v i r u s  e n t r y  i n  t h e  C N S  ( 4 ) .  O n  t h e  o t h e r  
hand, TLR3 demonstrated its protective role by restricting viral 
replication in neurons infected with WNV (43). Thus, the ex-
act  contribution  of  TLR3  in  WNV  infection  remains  con-
troversial but likely involves both cell-intrinsic and -extrinsic 
pathways. In a recent study, JEV induced a functional impair-
ment of dendritic cells (DCs), thereby dampening the CD4
＋ 
and CD8
＋ T cell responses that would normally be effective 
in fighting off the JEV infection (44). The functional modu-
lation  of  DCs  by  JEV  infection  appeared  to  be  mediated 
through the pan-adaptor molecule involved in TLR signaling, 
MyD88, both in dependent and independent manners. This 
indicates  that  TLRs  may  be  involved  in  JEV  pathogenesis. 
However, the role of each TLR molecule in JEV neuropatho-
genesis  needs  to  be  elucidated.
    HSV is the most commonly diagnosed virus of sporadic en-
cephalitis in humans. HSV-1 is usually acquired during child-
hood and often presents as a self-limiting pharyngitis. A sub-
sequent reactivation of latently infected HSV-1 is associated 
with perioral lesions, termed ٘fever blisters.ٙ In the neonates, 
HSV-1 and HSV-2 cause very different diseases manifested by 
sepsis-like symptoms including blood pressure instability, dis-
seminated intravascular coagulation, sometimes shock, and le-
thal encephalitis (45). Several TLR molecules are involved in 
the recognition of HSV infection. It has been reported the lev-
el of TLR2 expression increases in the brain in response to 
peripheral challenge with TLR2 bacterial ligands (46). HSV-1 
induces inflammatory cytokines through TLR2 in both TLR2- 
transfected cell lines and mice (47). In vivo studies have dem-TLRs and CD4
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onstrated that TLR2-deficient mice have a blunted cytokine re-
sponse and these mice are much less susceptible to normally 
lethal HSV1-induced encephalitis (47), which suggests that in-
duction of inflammatory cytokines through TLR2 may lead to 
encephalitis (47). HSV is a double-stranded DNA (dsDNA) vi-
rus  known  to  have  a  double-stranded  RNA  (dsRNA)  inter-
mediate usually recognized by TLR3. Upon TLR3 recognition 
o f  t h e  d s R N A  d e r i v e d  f r o m  H S V - 1  r e p l i c a t i o n ,  t h e  N F - κ B 
pathway  is  activated,  leading  to  production  of  type-I  IFNs 
(48), which are crucial for HSV clearance (49). A recent study 
showed that the synthetic TLR3 agonist has protective effects 
in lethal HSV-1 encephalitis (50). Also, TLR3 is expressed in 
the CNS, where it is required to control of HSV-1 replication 
(51). A genetic study reported a dominant-negative TLR3 al-
lele  in  otherwise  healthy  children  with  HSV-1  encephalitis 
(51). These reports suggest that both the TLR3 response and 
the evolutionary maintenance of TLR3 might be involved in 
HSV-1  encephalitis  (50,51).  Moreover,  TLR3-mediated  im-
munity is essential for protection against HSV-1 in the CNS 
during  the primary  infection in  childhood (52). It was  also 
suggested that TLR3 has largely redundant functions for re-
sponses to dsRNA and HSV-1 in various leukocytes, probably 
accounting for redundancy of TLR3 responses in the host de-
fense against HSV-1 outside the CNS (52). Since HSV DNA 
a l s o  c o n t a i n s  C p G  m o t i f s  t h a t  c a n  b e  r e c o g n i z e d  t h r o u g h  
TLR9  (53,54),  interferon-producing  cells  and  plasmacytoid 
DCs  are  activated  through  the  TLR9  signaling  pathway 
(53,54).
    Finally, rabies virus, another cause of neurological disease 
cause,  is  known  to  upregulate  IFN-β,  chemokines  (CCL-5, 
CXCL-10) and inflammatory cytokines (IL-6, TNF-α, IL-1β) 
for  TLR3-positive  neurons  (55).  The  activation  of  the  TLR3 
s i g n a l  p a t h w a y  i n d i c a t e s  a  p o s s i b l e  r o l e  f o r  T L R 3  s i g n a l i n g  
in the innate recognition of rabies virus infection (55). In sup-
port of this, TLR3-deficient mice have also been reported to 
have reduced susceptibility to infections with the rabies virus 
(56).
THE ROLE OF CD4
＋ Th SUBSETS IN ACUTE VIRAL 
ENCEPHALITIS
Lineage decisions of CD4
＋ Th subsets
Naive CD4
＋ Th cells, upon encountering their cognate anti-
gens  presented  by  professional  antigen-presenting  cells 
(APCs), differentiate into effector cells that are characterized 
by their cytokine production profiles and immune-regulatory 
f u n c t i o n s .  T h e  h e t e r o g e n e i t y  o f  e f f e c t o r  T  c e l l s  w a s  d i s -
covered two decades ago, at which time they were divided 
into two subsets, named Th1 or Th2 cells (57). Th1 differ-
entiation requires IL-12 and the transcription factors STAT4, 
STAT1  and  T-bet  (58),  whereas  Th2  differentiation  requires 
IL-4 and the transcription factors STAT6 and GATA3 (59). A 
third effector subset in addition to Th1 and Th2 cells has been 
identified in recent years, the Th17 subset, the differentiation 
of which is induced by the combination of TGF-β and IL-6 
(59,60). Recently, IL-21 was reported as an autocrine factor 
induced by IL-6 to regulate Th17 cell differentiation (60,61). 
STAT3, which is downstream of IL-6 and IL-21, is essential 
for  RORγt  and  RORα expression  and  Th17  cell  differ-
entiation (61). Additional T cell subsets were also discovered 
and  studied,  including  T  follicular  helper  (Tfh)  cells  and 
IL-9-expressing ٘Th9ٙ cells. In addition to these effector CD4
＋ 
Th subsets, there are regulatory subsets that help maintain im-
m u n e  h o m e o s t a s i s  b y  s u p p r e s s i n g  t h e  e f f e c t o r  T  c e l l  r e -
sponses.  This  helps  restrain  unwanted  immune  responses, 
thus preventing chronic inflammation and immune hyper-re-
sponsiveness (i.e., allergies). The thymus-derived natural reg-
ulatory T (nTreg) cells represent a unique subpopulation of 
CD4
＋  T  cells  and  express  the  Foxp3  transcription  factor, 
which is the hallmark of nTregs. Expresion of Foxp3 is essen-
tial for the Treg function in this regulatory subset (62). TGF-
β has also been shown to be an important cytokine for the 
maintenance of peripheral nTreg cells. Additionally, naive T 
cells  in  the  periphery  can  be  induced  to  express  Foxp3  in 
the  presence  of  TGF-β,  thus  becoming  inducible  Treg 
(iTreg) cells that exhibit a suppressive phenotype similar to 
the nTreg cells (62). Lineage fate decisions of CD4
＋ Th sub-
set are instructed by distinct environmental cytokines which 
signals through STAT or other inducible but generally ubiq-
uitous  transcription  factors.  Though  extensive  cross-regu-
lations among lineage-determining transcription factors exist, 
a  growing  body  of  evidence  suggests  that  Th  cell  lineage 
commitment  can  be  plastic  in  certain  circumstances.
The role of CD4
＋ Th subsets in viral encephalitis with 
special emphasis on Treg and Th17 cells
The presence of the BBB in the central nervous system that 
restricts  the  entry  of  cells  and  proteins,  the  restricted  ex-
pression of MHC antigens, and the nonrenewable nature of 
the neuronal cell population offer challenges to the immune 
system for viral clearance and increase the chance for viral 
persistence.  However,  vigorous  immune  responses  are TLRs and CD4
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mounted rapidly within the CNS against both self and exoge-
nous antigens in the face of an antigenic challenge. The lym-
phocyte subsets that constitute the protective T-cell responses 
within the CNS have not been fully characterized. During vi-
ral infection, most CD4
＋ T cells isolated from the virus-tar-
geted  organs  are  of  the  Th1  type  (63),  and  Th1  cytokines, 
such as IFN-γ, display strong antiviral function and antago-
nize the development of Th17 cells (64). In contrast to this 
protective  strategy,  a  virus  may  be  able  to  evade  antiviral 
type-I and -II IFN responses (65), facilitating its persistence 
in  the  host  by  inducing  elevated  levels  of  IL-17-producing 
CD4
＋ and/or CD8
＋ T cells. This is particularly true in case 
of chronic viral infections, for example in the Theilerٗs mur-
ine encephalitis virus (TMEV) infection (66). However, Th1 
cells may also play a harmful role in viral encephalitis, rather 
than their host-protective functions which depend on induc-
ing an antiviral cytokine environment. In experimental auto-
immune encephalitis, for instance, myelin-reactive Th1 cells 
in the absence of the IL-17
＋ Th17 cells show profound in-
flammatory  activity  (67). They  can  access the  non-inflamed 
CNS, establish EAE, and facilitate the entry of Th17 cells to 
the CNS during EAE. Th2 cells are known to mediate humoral 
immunity against extracellular pathogens. Humoral immunity 
driven by B cells with Th2 cell leads to the inhibition of viral 
replication and spread in the initial stages. For example, virus 
neutralizing  antibody-mediated  inhibition  of  JEV  replication 
leads to the inhibition of the cytopathic effects of the virus 
and hence less tissue damage in Japanese encephalitis (68). 
CD4
＋ T h2  ce ll s ma y pr ov id e  a  p ro te c ti ve  ro le  a g ain st  vi ral 
encephalitis during infection with neurotrophic virus. JEV was 
known to produce CD4
＋ Th2 responses associated with im-
munoprotection  against  acute  viral  encephalitis  in  adoptive 
transfer  model  studies  (69).
    IL-17-producing Th17 cells are apparently involved in in-
flammatory tissue damage, leading to the pathogenesis of var-
ious autoimmune diseases (67,70). Prior to the discovery of 
Th17 lineage of CD4
＋ T cells, Th1 cells were thought to be 
implicated  in  the  development  of  autoimmune  diseases. 
However,  more  recent  lines  of  evidence  suggest  that  Th17 
c e l l s ,  r a t h e r  t h a n  T h 1  c e l l s ,  a r e  t h e  t r u e  c u l p r i t s  i n  t h e  i n -
duction  and  progression  of  many  autoimmune  diseases. 
Indeed, IL-17 expression has been detected in the serum and 
t a r g e t  t i s s u e s  o f  p a t i e n t s  w i t h  v a r i o u s  a u t o i m m u n e  d i s e a s e s 
such as RA, multiple sclerosis (MS), and systemic lupus eryth-
ematous  (SLE).  Similarly,  the  production  of  IL-17  has  also 
been  reported  in  several  viral  infections,  for  example,  HIV 
infection in humans (71) and herpes simplex virus (72) and 
respiratory syncytial virus infections (73) in rodents. However, 
a persistent viral infection (eg. TMEV infection) preferentially 
induces  the  development  of  Th17  cells,  and  in  turn,  these 
cells uniquely promote the viral persistence via IL-17 by in-
hibiting apoptosis of infected cells as well as by desensitizing 
target  cell  killing  by  T  effector  cells  (66).
  Treg, a subset of CD4
＋ T cells, are now well-recognized 
for their modulatory functions and play pivotal roles in main-
taining immune homeostasis and preventing autoimmune dis-
eases (74,75). The outcome of viral infections is dependent 
upon  complex  interactions  between  the  pathogen  and  the 
balance of pro- and anti-inflammatory immune responses by 
the host. Excessive T cell responses have been implicated in 
disease in mice infected with lymphocytic choriomeningitis vi-
rus (LCMV), herpes simplex virus, or respiratory syncytial vi-
rus, with tissue damage during the process of virus clearance 
(76-78). To minimize excessive pro-inflammatory responses, 
anti-inflammatory  cells,  such  as  regulatory  T  cells  and  the 
I L - 1 0  p r o d u c i n g  T r 1  c e l l s  ( 7 9 ) ,  a r e  i n d u c e d  d u r i n g  a  v i r a l  
infection. An appropriate anti-inflammatory response will pre-
vent disease caused by immune responses without adversely 
affecting  virus  clearance.
    In healthy individuals, lymphocytic trafficking into the CNS 
is very low and tightly controlled by the highly specialized 
BBB. However, several pathological conditions of the CNS, 
such as viral or bacterial infections or inflammation-mediated 
disorders,  induce  circulating  lymphocytes  to  cross  the  BBB 
and gain access to the inflammatory foci (80). This may be 
a critical step for Treg to perform their biological function in 
i n f l a m m a t o r y  d i s e a s e s  o f  t h e  C N S .  A l t e r n a t i v e l y ,  t h e  T r e g  
function can be mediated by their soluble factors, even with-
o u t  t h e i r  a c t u a l  e x t r a v a s a t i o n  t o  t h e  i n f e c t e d  s i t e s .  R e c e n t  
studies revealed that several viruses belonging to the Flavivir-
idae  family,  such  as  the  classical  swine  fever  virus  (CSFV), 
dengue  virus  (DV),  JEV,  and  Yellow  fever  virus  (YFV),  in-
fected  DCs  and  altered  the  cell  phenotype  and  function 
(81-83). Furthermore, Aleyas et al. (2009) recently reported 
that the Beijing-strain of JEV replicates both in bmDCs and 
macrophages and induced the functional impairment of DCs 
through MyD88-dependent and independent pathways, which 
subsequently led to poor CD4
＋ and CD8
＋ T cell responses 
(44). These findings suggest that the virus-induced alteration 
of DCs is likely a cause for immunosuppression mediated by 
Tregs. The neuronal protective effects of Tregs were found 
to  play  a  role  in  several  viral-encephalitis  such  as  human TLRs and CD4
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Figure 1. IL-6 may be a key molecule in regulating the balance of 
differentiation between CD4
＋Foxp3




HIV-1 encephalitis (84), Japanese encephalitis (85), and West 
Nile encephalitis (6). In Japanese encephalitis, the JEV P3 in-
fection of DCs led to an expansion of CD4
＋ Foxp3
＋ regu-
latory T cells (Treg) with immunosuppressive potential. This 
suggests that the JEV-induced alteration of DCs may have ini-
t i a t e d  t h e  i m m u n o s u p p r e s s i o n  b y  i T r e g s  ( 8 5 ) .  A l s o ,  C D 4
＋
Foxp3
＋ Tregs, expanded by the WNV infection, may regulate 
the development of virus-caused encephalitis in humans and 
mice (6). However, further studies will be required to eluci-
date how Tregs ameliorate clinical encephalitis after a neuro-
trophic  virus  infection.
PLASTICITY OF Th17 AND Treg CELLS AND THEIR 
BALANCE IN VIRAL ENCEPHALITIS
The balance between Th17 and Treg is crucial for immune 
h o m e o s t a s i s .  T h e  p l a s t i c i t y  i n  t h e  T h 1 7  a n d  T r e g  d e v e l -
opmental programs play a pivotal role in maintaining immune 
homeostasis,  allowing  the  regulation  of  anti-inflammatory 
Tregs  and  pro-inflammatory  Th17  cell  differentiation  from 
naïve Th precursors. Although nTregs develop during thymic 
selection through a TGF-β-independent mechanism, the ex-
trathymic  development  of  iTregs  is  TGF-β-dependent. 
Development of Th17 cells is also TGF-β-dependent, but ad-
ditional coordinate signaling by IL-6 produced from DC and 
other cells activated by microbial products, is required in con-
cert  with  TGF-β to  induce  Th17  differentiation.  In  other 
words,  priming  of  naïv e  C D 4  T  c e l l s  b y  a n  a n t i g e n  i n  t h e  
presence  of  active  TGF-β promotes  the  development  of 
iTregs  in  the  absence  of  pro-inflammatory  signals  from  the 
innate immune system, whereas Th activation in an environ-
ment where both active TGF-β and IL-6 are available pro-
motes  Th17  development.  Because  TGF-β suppresses  Th1 
and Th2 differentiation (86), iTreg and Th17 development are 
favored  in  its  presence.  The  transcription  factor  central  to 
Th17 differentiation is an isoform of the retinoic acid-related 
orphan  receptor  γ,  RORγ,  which  is  expressed  in  T  cells 
(RORγt )  ( 8 7 )  a n d  d i r e c t s  t h e  d i f f e r e n t i a t i o n  p r o g r a m  f o r  
pro-inflammatory IL-17
＋ T helper cells. A second member of 
the ROR family, RORα, is also associated with the Th17 de-
velopment  program  (61),  but  its  contribution  appears 
dispensable. On the other hand, the transcription factor cen-
tral  to  Treg  differentiation  and  function  is  Foxp3.  Interest-
ingly, naïve T cells stimulated with TGF-β alone were found 
to upregulate both Foxp3 and RORγt. However, as Foxp3 
is able to associate with RORγt and inhibit RORγt transcrip-
tional activation, treatment of naïve T cells with TGF-β led 
exclusively to Treg differentiation (88). Therefore, the balance 
of  TGF-β and  IL-6  signaling  might  determine  the  differ-
entiation of iTregs or Th17 cells through an antagonistic com-
petition  of  Foxp3  and  RORγt  (Fig.  1).
    Several studies recently reported that all-trans retinoic acid 
(at-RA), derived from Vitamin A, can potently inhibit Th17 de-
velopment and promote iTreg development, at least in part 
by antagonizing the effects of IL-6 (89-91). This implies that 
interactions between Foxp3 and ROR factors could be directly 
or indirectly modulated by the binding of retinoic acid to the 
retinoic acid receptor, RAR, although specific mechanisms by 
which this might occur are unclear. Thus, IL-6 acts as a po-
tent pro-inflammatory cytokine in T cells through promotion 
of Th17differentiation and inhibiting Treg differentiation, in-
dicating  that  modulating  IL-6  levels  may  normalize  the bal-
ance between Th17 and Treg in viral encephalitis and may 
alleviate  clinical  severity.
CONCLUSION AND FUTURE PERSPECTIVES
As illustrated in this review, the studies on the immune-patho-
logical progression of acute viral encephalitis caused by neu-
rotropic virus have been accumulated gradually in the recent 
years, along with the discovery of key molecules that control 
the  development  of  acute  encephalitis  caused  by  infection 
with the neurotrophic virus. Notably, mosquito-borne viruses 
that  induce  acute  encephalitis  are  becoming  pandemic  in-
fectious agents due to the changes in the ecosystem, global 
warming, and modern transportation. Paradoxically, the pro-
tective immune responses in the periphery that reduce viral TLRs and CD4
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burden  may  generate  inflammatory  mediators  that  sub-
sequently alter the permeability of the BBB to allow free virus 
and/or virus-infected leukocytes to enter the CNS. The acute 
encephalitis caused by neurotrophic viruses is a complex im-
mune-pathological phenomenon played by molecules related 
to innate and adaptive immunity. For the migration of periph-
eral  leukocytes  into  the  CNS,  a  gradient  of  chemokines 
should be established. Thus, it will be interesting to define 
the molecules that control the entry of leukocytes into CNS, 
such as TLRs and chemokines/chemokine receptors. Further-
more,  the  regulation  of  fatal  neuro-inflammation  caused  by 
viral infection will be achieved by suppressive cellular media-
tors,  such  as  CD4
＋Foxp3
＋  Tregs  and  CD11b
＋Gr-1
＋ m y e -
loid-derived suppressive cells (MDSCs). However, despite the 
pathological  importance  of  acute  viral  encephalitis,  the  im-
mune-pathological  mechanisms  occurring  during  the  pro-
gression of encephalitis and roles played by CD4
＋ Th sub-
sets, especially IL-17-producing Th17 and CD4
＋Foxp3
＋ Treg 
cells, still remain undefined. Therefore, the future challenge 
will be to unravel the functions of molecules related to such 
cellular subsets in the proper host context. An improved un-
derstanding of the molecular signals that govern the functions 
of regulatory cell components may advance the development 
o f  t h e r a p e u t i c  a p p r o a c h e s  t h a t  e f f e c t i v e l y  t r e a t  a c u t e  v i r a l  
encephalitis.
ACKNOWLEDGEMENTS
T h i s  s t u d y  w a s  s u p p o r t e d  b y  t h e  M i d - c a r e e r  R e s e a r c h  P r o -
gram (2011-0029825) and the Indo-Korean Joint Programme 
of  Cooperation  in  Science  and  Technology  (2011-0027170) 
through  the  National  Research  Foundation  of  Korea  (NRF) 
funded  by  the  Ministry  of  Education,  Science  and  Tech-
nology.
CONFLICTS OF INTEREST
The  authors  have  no  financial  conflict  of  interest.
REFERENCES
1. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos 
KL,  Hartman  BJ,  Kaplan  SL,  Scheld  WM,  Whitley  RJ; 
Infectious Diseases Society of America: The management of 
encephalitis:  clinical  practice  guidelines  by  the  Infectious 
Diseases Society of America. Clin Infect Dis 47;303-327, 2008.
2. Johnston LJ, Halliday GM, King NJ: Langerhans cells migrate 
to local lymph nodes following cutaneous infection with an 
arbovirus.  J  Invest  Dermatol  114;560-568,  2000.
3. Solomon T, Vaughn DW: Pathogenesis and clinical features 
of Japanese encephalitis and West Nile virus infections. Curr 
Top  Microbiol  Immunol  267;171-194,  2002.
4. Wang  T,  Town  T,  Alexopoulou  L,  Anderson  JF,  Fikrig  E, 
Flavell RA: Toll-like receptor 3 mediates West Nile virus entry 
into the brain causing lethal encephalitis. Nat Med 10;1366- 
1373,  2004.
5. Wolinsky JS: Subacute sclerosing panencephalitis, progressive 
rubella panencephalitis, and multifocal leukoencephalopathy. 
Res  Publ  Assoc  Res  Nerv  Ment  Dis  68;259-268,  1990.
6. Lanteri MC, OٗBrien KM, Purtha WE, Cameron MJ, Lund JM, 
Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, 
Kiely  N,  Prince  HE,  Ndhlovu  LC,  Nixon  DF,  Kamel  HT, 
Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ: 
Tregs control the development of symptomatic West Nile vi-
rus  infection  in  humans  and  mice.  J  Clin  Invest  119;3266- 
3277,  2009.
7. Morse  SS:  Factors  in  the  emergence  of  infectious diseases. 
Emerg  Infect  Dis  1;7-15,  1995.
8. Mackenzie JS, Gubler DJ, Petersen LR: Emerging flaviviruses: 
the  spread  and  resurgence  of  Japanese  encephalitis,  West 
Nile and dengue viruses. Nat Med 10(12 Suppl);S98-109, 2004.
9. Jia XY, Briese T, Jordan I, Ram baut A, Chi HC, M ackenzie 
JS, Hall RA, Scherret J, Lipkin WI: Genetic analysis of West 
Nile New York 1999 encephalitis virus. Lancet 354;1971-1972, 
1999.
10. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele 
K,  Crise  B,  Volpe  KE,  Crabtree  MB,  Scherret  JH,  Hall  RA, 
MacKenzie JS, Cropp CB, Panigrahy B, Ostlund E, Schmitt B, 
Malkinson M, Banet C, Weissman J, Komar N, Savage HM, 
Stone W, McNamara T, Gubler DJ: Origin of the West Nile 
virus responsible for an outbreak of encephalitis in the north-
eastern  United  States.  Science  286;2333-2337,  1999.
1 1. Lanciotti R S, E bel G D , D eu bel V , K erst A J, M urri S, M e yer 
R, Bowen M, McKinney N, Morrill WE, Crabtree MB, Kramer 
LD, Roehrig JT: Complete genome sequences and phyloge-
netic  analysis  of  West  Nile  virus  strains  isolated  from  the 
United States, Europe, and the Middle East. Virology 298;96- 
105,  2002.
1 2 .H a n n a  J N ,  R i t c h i e  S A ,  P h i l l i p s  D A ,  S h i e l d  J ,  B a i l e y  M C ,  
Mackenzie JS, Poidinger M, McCall BJ, Mills PJ: An outbreak 
of Japanese encephalitis in the Torres Strait, Australia, 1995. 
Med  J  Aust  165;256-260,  1996.
13. Ritchie SA, Phillips D, Broom A, Mackenzie J, Poidinger M, 
van den Hurk A: Isolation of Japanese encephalitis virus from 
Culex annulirostris in Australia. Am J Trop Med Hyg 56;80-84, 
1997.
14. Mackenzie JS.  Emergence of  Japanese encephalitis  virus  in 
t h e  A u s t r a l a s i a n  r e g i o n .  I n :  S a l u z z o  J F ,  D o d e t  B ,  e d i t o r s .  
Factors  in  the  emergence  of  arbovirus  diseases.  Paris: 
Elsevier;  p191-201,  1997.
15. Hanna JN, Ritchie SA, Phillips DA, Lee JM, Hills SL, van den 
Hurk AF, Pyke AT, Johansen CA, Mackenzie JS: Japanese en-
cephalitis in north Queensland, Australia, 1998. Med J Aust 
170;533-536,  1999.
16. Solomon T: Flavivirus encephalitis. N Engl J Med 351;370-378, TLRs and CD4
＋ Th Subsets in Acute Viral Encephalitis
Young Woo Han, et al.
55 IMMUNE NETWORK http://www.ksimm.or.kr Volume 12 Number 2 April 2012
2004.
17. Solomon  T:  Control  of  Japanese  encephalitis--within  our 
grasp?  N  Engl  J  Med  355;869-871,  2006.
18. Burke DS, Leake CJ. Japanese encephalitis. In: Monath TP, 
editor.  The  arboviruses:  epidemiology  and  ecology.  Boca 
Raton:  CRC  Press;  63-92,  1988.
19. Innis  BL.  Japanese  encephalitis.  In:  Porterfield  JS,  editor. 
Exotic viral infections. London: Chapman & Hall; p147-173, 
1995.
20. Endy TP, Nisalak A: Japanese encephalitis virus: ecology and 
epidemiology. Curr Top Microbiol Immunol 267;11-48, 2002.
21. Vaughn DW, Hoke CH Jr: The epidemiology of Japanese en-
cephalitis:  prospects  for  prevention.  Epidemiol  Rev  14;197- 
221,  1992.
2 2 .K u m a r  R ,  M a t h u r  A ,  K u m a r  A ,  S e t h i  G D ,  S h a r m a  S ,  
Chaturvedi UC: Virological investigations of acute encephal-
opathy  in  India.  Arch  Dis  Child  65;1227-1230,  1990.
23. Ghoshal A, Das S, Ghosh S, Mishra MK, Sharma V, Koli P, 
Sen E, Basu A: Proinflammatory mediators released by acti-
vated  microglia  induces  neuronal  death  in  Japanese  ence-
phalitis.  Glia  55;483-496,  2007.
24. Chen CJ, Chen JH, Chen SY, Liao SL, Raung SL: Upregulation 
of RANTES gene expression in neuroglia by Japanese ence-
phalitis  virus  infection.  J  Virol  78;12107-12119,  2004.
25. Ravi V, Parida S, Desai A, Chandramuki A, Gourie-Devi M, 
Grau GE: Correlation of tumor necrosis factor levels in the 
serum  and  cerebrospinal  fluid  with  clinical  outcome  in 
Japanese encephalitis patients. J Med Virol 51;132-136, 1997.
26. Swarup V, Ghosh  J, Duseja R, Ghosh S, Basu A: Japanese 
encephalitis virus infection decrease endogenous IL-10 pro-
duction:  correlation  with  microglial  activation  and  neuronal 
death.  Neurosci  Lett  420;144-149,  2007.
27. Takeda K, Akira S: Toll-like receptors in innate immunity. Int 
Immunol  17;1-14,  2005.
28. Meylan E, Tschopp J: Toll-like receptors and RNA helicases: 
two  parallel  ways  to  trigger  antiviral  responses.  Mol  Cell 
22;561-569,  2006.
29. Janeway  CA  Jr,  Medzhitov  R:  Innate  immune  recognition. 
Annu  Rev  Immunol  20;197-216,  2002.
3 0 .B a r t o n  G M ,  M e d z h i t o v  R :  T o l l - l i k e  r e c e p t o r s  a n d  t h e i r  
ligands.  Curr  Top  Microbiol  Immunol  270;81-92,  2002.
31. Medzhitov  R:  Toll-like  receptors  and  innate  immunity.  Nat 
Rev  Immunol  1;135-145,  2001.
32. Heine H, Lien E: Toll-like receptors and their function in in-
nate  and  adaptive  immunity.  Int  Arch  Allergy  Immunol 
130;180-192,  2003.
33. Dunne A, OٗNeill LA: The interleukin-1 receptor/Toll-like re-
ceptor  superfamily:  signal  transduction  during  inflammation 
and  host  defense.  Sci  STKE  2003;re3,  2003.
34. Zhang  H,  Tay  PN,  Cao  W,  Li  W,  Lu  J:  Integrin-nucleated 
Toll-like receptor (TLR) dimerization reveals subcellular tar-
g e t i n g  o f  T L R s  a n d  d i s t i n c t  m e c h a n i s m s  o f  T L R 4  a c t i v a t i o n 
and  signaling.  FEBS  Lett  532;171-176,  2002.
3 5 . C o m p t o n  T ,  K u r t - J o n e s  E A ,  B o e h m e  K W ,  B e l k o  J ,  L a t z  E , 
Golenbock  DT,  Finberg  RW:  Human  cytomegalovirus  acti-
vates inflammatory cytokine responses via CD14 and Toll-like 
receptor  2.  J  Virol  77;4588-4596,  2003.
36. Düesberg U, von dem Bussche A, Kirschning C, Miyake K, 
Sauerbruch  T,  Spengler  U:  Cell  activation  by  synthetic  lip-
opeptides of the hepatitis C virus (HCV)--core protein is medi-
a t e d  b y  t o l l  l i k e  r e c e p t o r s  ( T L R s )  2  a n d  4 .  I m m u n o l  L e t t  
84;89-95,  2002.
37. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR: Murine 
retroviruses activate B cells via interaction with toll-like re-
ceptor  4.  Proc  Natl  Acad  Sci  U  S  A  99;2281-2286,  2002.
38. Zarember  KA,  Godowski  PJ:  Tissue  expression  of  human 
Toll-like receptors and differential regulation of Toll-like re-
ceptor mRNAs in leukocytes in response to microbes, their 
products,  and  cytokines.  J  Immunol  168;554-561,  2002.
3 9 . G e w i r t z  A T ,  N a v a s  T A ,  L y o n s  S ,  G o d o w s k i  P J ,  M a d a r a  J L : 
Cutting  edge:  bacterial  flagellin  activates  basolaterally  ex-
pressed  TLR5  to  induce  epithelial  proinflammatory  gene 
expression.  J  Immunol  167;1882-1885,  2001.
40. Modlin  RL:  Mammalian  toll-like  receptors.  Ann  Allergy 
Asthma  Immunol  88;543-547,  2002.
41. Town T,  Bai  F,  Wang T,  Kaplan  AT,  Qian  F, Montgomery 
RR, Anderson JF, Flavell RA, Fikrig E: Toll-like receptor 7 miti-
gates lethal West Nile encephalitis via interleukin 23-depen-
dent immune cell infiltration and homing. Immunity 30;242- 
253,  2009.
42. Szretter KJ, Daffis S, Patel J, Suthar MS, Klein RS, Gale M Jr, 
Diamond MS: The innate immune adaptor molecule MyD88 
restricts West Nile virus replication and spread in neurons of 
the  central  nervous  system.  J  Virol  84;12125-12138,  2010.
43. Daffis  S,  Samuel  MA,  Suthar  MS,  Gale  M  Jr,  Diamond  MS: 
T oll-like  re cep to r 3  has a p rotectiv e role  ag ain st W est N ile 
virus  infection.  J  Virol  82;10349-10358,  2008.
44. Aleyas AG, George JA, Han YW, Rahman MM, Kim SJ, Han 
SB, Kim BS, Kim K, Eo SK: Functional modulation of dendritic 
cells and macrophages by Japanese encephalitis virus through 
MyD88 adaptor molecule-dependent and -independent path-
ways.  J  Immunol  183;2462-2474,  2009.
45. Kimberlin DW: Herpes simplex virus infections of the central 
nervous  system.  Semin  Pediatr  Infect  Dis  14;83-89,  2003.
46. Oliveira RB, Ochoa MT, Sieling PA, Rea TH, Rambukkana A, 
Sarno EN, Modlin RL: Expression of Toll-like receptor 2 on 
human  Schwann  cells:  a  mechanism  of  nerve  damage  in 
leprosy.  Infect  Immun  71;1427-1433,  2003.
47. Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson 
R, Arnold MM, Knipe DM, Finberg RW: Herpes simplex virus 
1  interaction  with  Toll-like  receptor  2  contributes  to  lethal 
encephalitis. Proc Natl Acad Sci U S A 101;1315-1320, 2004.
48. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA: Recogni-
tion of double-stranded RNA and activation of NF-kappaB by 
Toll-like  receptor  3.  Nature  413;732-738,  2001.
4 9 .G i l l  N ,  D e a c o n  P M ,  L i c h t y  B ,  M o s s m a n  K L ,  A s h k a r  A A :  
Induction  of  innate  immunity  against  herpes  simplex  virus 
type 2 infection via local delivery of Toll-like receptor ligands 
correlates  with  beta  interferon  production.  J  Virol  80;9943- 
9950,  2006.
50. Boivin N, Sergerie Y, Rivest S, Boivin G: Effect of pretreat-
ment with toll-like receptor agonists in a mouse model of her-
pes simplex virus type 1 encephalitis. J Infect Dis 198;664- 
672,  2008.
51. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero 
P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, TLRs and CD4
＋ Th Subsets in Acute Viral Encephalitis
Young Woo Han, et al.
56 IMMUNE NETWORK http://www.ksimm.or.kr Volume 12 Number 2 April 2012
Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth 
H,  Ku  CL,  Casrouge  A,  Zhang  XX,  Barreiro  L,  Leonard  J, 
Hamilton C, Lebon P, Héron B, Vallée L, Quintana-Murci L, 
Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu 
M, Abel L, Casanova JL: TLR3 deficiency in patients with her-
pes  simplex  encephalitis.  Science  317;1522-1527,  2007.
52. Guo Y, Audry M, Ciancanelli M, Alsina L, Azevedo J, Herman 
M,  Anguiano  E,  Sancho-Shimizu  V,  Lorenzo  L,  Pauwels  E, 
Philippe PB, Pére z  d e  D ie g o  R , C a rd o n  A , V o g t G , P ic a rd 
C, Andrianirina ZZ, Rozenberg F, Lebon P, Plancoulaine S, 
Tardieu  M,  Valérie  Doireau,  Jouanguy  E,  Chaussabel  D, 
Geissmann F, Abel L, Casanova JL, Zhang SY: Herpes simplex 
virus encephalitis in a patient with complete TLR3 deficiency: 
TLR3 is otherwise redundant in protective immunity. J Exp 
Med  208;2083-2098,  2011.
53 . K rug  A , Lu ke r G D , B arch et W , Leib D A , A k ira S, C olonn a 
M: Herpes simplex virus type 1 activates murine natural inter-
feron-producing  cells  through  toll-like  receptor  9.  Blood 
103;1433-1437,  2004.
54. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A: Toll-like re-
ceptor 9-mediated recognition of Herpes simplex virus-2 by 
plasmacytoid  dendritic  cells.  J  Exp  Med  198;513-520,  2003.
55. Préhaud  C,  Mégret  F,  Lafage  M,  Lafon  M:  Virus  infection 
switches  TLR-3-positive  human  neurons  to  become  strong 
producers  of  beta  interferon.  J  Virol  79;12893-12904,  2005.
56. Ménager P, Roux P, Mégret F, Bourgeois JP, Le Sourd AM, 
Danckaert  A,  Lafage  M,  Préhaud  C,  Lafon  M:  Toll-like  re-
ceptor 3 (TLR3) plays a major role in the formation of rabies 
virus  Negri  Bodies.  PLoS  Pathog  5;e1000315,  2009.
57. Mosmann TR, Coffman RL: TH1 and TH2 cells: different pat-
terns  of  lymphokine  secretion  lead  to  different  functional 
properties.  Annu  Rev  Immunol  7;145-173,  1989.
58. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, Glimcher 
LH: A novel transcription factor, T-bet, directs Th1 lineage 
commitment.  Cell  100;655-669,  2000.
59. Zheng W, Flavell RA: The transcription factor GATA-3 is nec-
essary and sufficient for Th2 cytokine gene expression in CD4 
T  cells.  Cell  89;587-596,  1997.
60. Korn T, Bettelli E, Gao W, Awasthi A, Jäger  A,  Strom TB, 
Oukka M, Kuchroo VK: IL-21 initiates an alternative pathway 
to induce proinflammatory T(H)17 cells. Nature 448;484-487, 
2007.
61. Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, 
Chung  Y,  Ma  L,  Shah  B,  Panopoulos  AD,  Schluns  KS, 
Watowich SS, Tian Q, Jetten AM, Dong C: T helper 17 lineage 
differentiation  is  programmed  by  orphan  nuclear  receptors 
ROR  alpha  and  ROR  gamma.  Immunity  28;29-39,  2008.
62. Curiel TJ: Regulatory T-cell development: is Foxp3 the decid-
er?  Nat  Med  13;250-253,  2007.
63. Abbas AK, Murphy KM, Sher A: Functional diversity of helper 
T  lymphocytes.  Nature  383;787-793,  1996.
64. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, 
Murphy KM, Weaver CT: Interleukin 17-producing CD4＋ ef-
fector T cells develop via a lineage distinct from the T helper 
type  1  and  2  lineages.  Nat  Immunol  6;1123-1132,  2005.
65. Sen  GC:  Viruses  and  interferons.  Annu  Rev  Microbiol  55; 
255-281,  2001.
66. Hou W, Kang HS, Kim BS: Th17 cells enhance viral persis-
tence  and  inhibit  T  cell  cytotoxicity  in  a  model  of  chronic 
virus  infection.  J  Exp  Med  206;313-328,  2009.
67. OٗConnor RA, Prendergast CT, Sabatos CA, Lau CW, Leech 
MD, Wraith DC, Anderton SM: Cutting edge: Th1 cells facili-
tate the entry of Th17 cells to the central nervous system dur-
ing experimental autoimmune encephalomyelitis. J Immunol 
181;3750-3754,  2008.
68. Iwasaki T, Ogura R: Studies on neutralization of Japanese en-
cephalitis virus (JEV). I. Further neutralization of the resistant 
virus fraction  by an  interactio n be tw ee n antiv irus Ig G  anti-
body  and  IgG  heterotype  or  allotype  antibody.  Virology 
34;141-148,  1968.
69. Biswas SM, Ayachit VM, Sapkal GN, Mahamuni SA, Gore MM: 
Japanese encephalitis virus produces a CD4＋ Th2 response 
and  associated  immunoprotection  in  an  adoptive-transfer 
murine  model.  J  Gen  Virol  90;818-826,  2009.
70. Ouyang W, Kolls  JK, Zheng Y: The biological functions of 
T helper 17 cell effector cytokines in inflammation. Immunity 
28;454-467,  2008.
71. Alfano M, Crotti A, Vicenzi E, Poli G: New players in cytokine 
control of HIV infection. Curr HIV/AIDS Rep 5;27-32, 2008.
72. Molesworth-Kenyon SJ, Yin R, Oakes JE, Lausch RN: IL-17 re-
ceptor  signaling  influences  virus-induced  corneal  inflamma-
tion.  J  Leukoc  Biol  83;401-408,  2008.
73. Hashimoto K, Durbin JE, Zhou W, Collins RD, Ho SB, Kolls 
JK, Dubin PJ, Sheller JR, Goleniewska K, OٗN eal JF, O lson 
SJ, Mitchell D, Graham BS, Peebles RS Jr: Respiratory syncytial 
virus infection in the absence of STAT 1 results in airway dys-
function, airway mucus, and augmented IL-17 levels. J Allergy 
Clin  Immunol  116;550-567,  2005.
74. Wing K, Sakaguchi S: Regulatory T cells exert checks and bal-
ances  on  self  tolerance  and  autoimmunity.  Nat  Immunol 
11;7-13,  2010.
75. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari 
Z,  Shimizu  J,  Takahashi  T,  Nomura  T:  Foxp3＋ CD25＋ 
CD4＋ natural regulatory T cells in dominant self-tolerance 
and  autoimmune  disease.  Immunol  Rev  212;8-27,  2006.
76. Hussell T, Pennycook A, Openshaw PJ: Inhibition of tumor 
necrosis  factor  reduces  the  severity  of  virus-specific  lung 
immunopathology.  Eur  J  Immunol  31;2566-2573,  2001.
77. Oldstone MB: Biology and pathogenesis of lymphocytic cho-
riomeningitis  virus  infection.  Curr  Top  Microbiol  Immunol 
263;83-117,  2002.
78. Suvas  S,  Azkur  AK,  Kim  BS,  Kumaraguru  U,  Rouse  BT: 
CD4＋CD25＋ regulatory T cells control the severity of viral 
immunoinflammatory lesions. J Immunol 172;4123-4132, 2004.
7 9 .R o n c a r o l o  M G ,  G r e g o r i  S ,  B a t t a g l i a  M ,  B a c c h e t t a  R ,  
Fleischhauer K, Levings MK: Interleukin-10-secreting type 1 
regulatory  T  cells  in  rodents  and  humans.  Immunol  Rev 
212;28-50,  2006.
80. Engelhardt B, Ransohoff RM: The ins and outs of T-lympho-
c y te  tra ffi c k in g  to  th e  C N S : a n a to m ic a l s i te s  a n d  m o le c u l a r 
mechanisms.  Trends  Immunol  26;485-495,  2005.
81. Ho LJ, Wang JJ, Shaio MF, Kao CL, Chang DM, Han SW, Lai 
JH: Infection of human dendritic cells by dengue virus causes 
cell  maturation  and  cytokine  production.  J  Immunol  166; 
1499-1506,  2001.
8 2 . C a r r a s c o  C P ,  R i g d e n  R C ,  V i n c e n t  I E ,  B a l m e l l i  C ,  C e p p i  M , TLRs and CD4
＋ Th Subsets in Acute Viral Encephalitis
Young Woo Han, et al.
57 IMMUNE NETWORK http://www.ksimm.or.kr Volume 12 Number 2 April 2012
Bauhofer  O,  Tâche V, Hjertner B, McNeilly F, van Gennip 
HG, McCullough KC, Summerfield A: Interaction of classical 
swine fever virus with dendritic cells. J Gen Virol 85;1633- 
1641,  2004.
83. Barba-Spaeth G, Longman RS, Albert ML, Rice CM: Live atte-
nuated yellow fever 17D infects human DCs and allows for 
presentation of endogenous and recombinant T cell epitopes. 
J  Exp  Med  202;1179-1184,  2005.
84. Gong  N,  Liu  J,  Reynolds  AD,  Gorantla  S,  Mosley  RL, 
Gendelman HE: Brain ingress of regulatory T cells in a mur-
ine model of HIV-1 encephalitis. J Neuroimmunol 230;33-41, 
2011.
85. Cao S, Li Y, Ye J, Yang X, Chen L, Liu X, Chen H: Japanese 
encephalitis  Virus  wild  strain  infection  suppresses  dendritic 
cells maturation and function, and causes the expansion of 
regulatory  T  cells.  Virol  J  8;39,  2011.
86. Li  MO,  Wan  YY,  Sanjabi  S,  Robertson  AK,  Flavell  RA: 
Transforming  growth  factor-beta  regulation  of  immune  re-
sponses.  Annu  Rev  Immunol  24;99-146,  2006.
87. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, 
Lafaille JJ, Cua DJ, Littman DR: The orphan nuclear receptor 
RORgammat  directs  the  differentiation  program  of  proin-
flammatory IL-17＋ T helper cells. Cell 126;1121-1133, 2006.
88. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, 
Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman 
DR:  TGF-beta-induced  Foxp3  inhibits  T(H)17  cell  differ-
entiation by antagonizing RORgammat function. Nature 453; 
236-240,  2008.
89. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg 
M, Cheroutre H: Reciprocal TH17 and regulatory T cell differ-
entiation  mediated  by  retinoic  acid.  Science  317;256-260, 
2007.
90. Coombes JL, Siddiqui KR, Arancibia-Cárcamo CV, Hall J, Sun 
CM,  Belkaid  Y,  Powrie  F:  A  functionally  specialized  pop-
ulation of mucosal CD103＋ DCs induces Foxp3＋ regulatory 
T cells via a TGF-beta and retinoic acid-dependent mecha-
nism.  J  Exp  Med  204;1757-1764,  2007.
91. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora 
JR, Belkaid Y: Small intestine lamina propria dendritic cells 
promote de novo generation of Foxp3 T reg cells via retinoic 
acid.  J  Exp  Med  204;1775-1785,  2007.